Vaccines and delivery technologies

Vaccines and delivery technologies

All topics related to vaccine products, presentation and packaging; also includes temperature indicators such as vaccine vial monitors (VVMs) and vaccine delivery devices.

K2_ThuAMUTCE_January+0000RJanAMUTC_4E04

Bharat Biotech today announced that the World Health Organization (WHO Geneva) has awarded prequalification to the developing world’s first rotavirus vaccine, ROTAVAC®. This vaccine to prevent infant deaths and hospitalizations due to rotavirus diarrhea was launched by the Hon’ble Prime Minister of India, Shri Narendra Modi in New Delhi in…

K2_TueAMUTCE_January+0000RJanAMUTC_2E03

Oxford University academics have been accused of misrepresenting unfavourable test results to get permission and funding for human trials of a potential vaccine aginst tuberculosis. An investigation by the BMJ claims that they took a “pick and mix approach” to pre-clinical research. Experts said that the investigation reflected wider concerns over regulation…

K2_MonAMUTCE_January+0000RJanAMUTC_1E03

The World Health Organisation (WHO) on Jan.03 endorsed the first conjugate vaccine for typhoid. Dubbed Typbar TVC, the vaccine which has been approved to be introduced by interested countries on their immunization programmes can be administered to children younger than two years of age. Unlike older vaccines, this is said…

K2_TuePMUTCE_January+0000RJanPMUTC_2E02

The WHO has given its nod to Bharat Biotech’s typhoid vaccine Typbar TCV, which has longer-lasting immunity than existing vaccines, requires fewer doses and can be used on recipients over six months of age. The WHO pre-qualification paves the way for health and humanitarian organisations such as UNICEF, GAVI and…

K2_TueAMUTCE_December+0000RDecAMUTC_2E50

Each year there are more than three million cases of cholera worldwide, a disease transmitted through contaminated food and water that hits developing countries particularly hard. While the standard regimen for protecting against cholera with existing non-living oral cholera vaccines includes administering two doses over a two-week period, research at…

K2_MonAMUTCE_December+0000RDecAMUTC_1E50

There were just 74 cases of polio reported worldwide in 2015. Thanks to a global vaccination drive, this crippling disease, which once affected hundreds of thousands of people a year, is now on the verge of extinction. The World Health Organisation estimates its eradication programme has saved around 5m people…

K2_TuePMUTCE_December+0000RDecPMUTC_2E49

A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday. The results, published in the journal Lancet, offer a first glimpse at the vaccine’s performance…

K2_WedPMUTCE_October+0000ROctPMUTC_3E41

China will allow the use of data from overseas clinical trials for approvals of new drugs, in a move likely to enable multinationals to bring products to the world’s second-largest pharmaceutical market more quickly. Pharmaceutical approvals in China can take up to seven years longer than in Europe and the…
Page 2 of 6